Risk of Cancer in Patients with Inflammatory Bowel Diseases: a Nationwide Population-Based Cohort Study with 30 Years of Follow Up
暂无分享,去创建一个
Sandler | H. Sørensen | R. Erichsen | J. Baron | D. Farkas | M. Kappelman | M. Long | S. Robert
[1] B. V. Pedersen,et al. Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years. , 2012, Gastroenterology.
[2] Christopher F. Martin,et al. Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel disease. , 2012, Gastroenterology.
[3] B. V. Pedersen,et al. Increased risk of inflammatory bowel disease in women with endometriosis: a nationwide Danish cohort study , 2011, Gut.
[4] J. Hugot,et al. Increased risk for nonmelanoma skin cancers in patients who receive thiopurines for inflammatory bowel disease. , 2011, Gastroenterology.
[5] Harminder Singh,et al. Increased risk of nonmelanoma skin cancers among individuals with inflammatory bowel disease. , 2011, Gastroenterology.
[6] Elsebeth Lynge,et al. The Danish National Patient Register , 2011, Scandinavian journal of public health.
[7] A. Jemal,et al. Cancer Statistics, 2010 , 2010, CA: a cancer journal for clinicians.
[8] J. West,et al. Risk of Cancer in Inflammatory Bowel Disease Treated With Azathioprine: A UK Population-Based Case–Control Study , 2010, The American Journal of Gastroenterology.
[9] P. Munkholm,et al. Risk of Extra-Intestinal Cancer in Inflammatory Bowel Disease: Meta-Analysis of Population-Based Cohort Studies , 2010, The American Journal of Gastroenterology.
[10] C. Porter,et al. Increased risk for non-melanoma skin cancer in patients with inflammatory bowel disease. , 2010, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[11] F. Carrat,et al. Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study , 2009, The Lancet.
[12] Ahmedin Jemal,et al. International Trends in Colorectal Cancer Incidence Rates , 2009, Cancer Epidemiology Biomarkers & Prevention.
[13] S. Galandiuk,et al. Smoking and inflammatory bowel disease: a meta-analysis. , 2006, Mayo Clinic proceedings.
[14] M. Wallander,et al. Risk factors for inflammatory bowel disease in the general population , 2005, Alimentary pharmacology & therapeutics.
[15] C. Brensinger,et al. Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine , 2005, Gut.
[16] P. Munkholm,et al. Long-term risk of cancer in ulcerative colitis: a population-based cohort study from Copenhagen County. , 2004, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[17] A. Zinsmeister,et al. Risk of lymphoma in inflammatory bowel disease , 2000, American Journal of Gastroenterology.
[18] L Frank,et al. When an Entire Country Is a Cohort , 2000, Science.
[19] T. F. Andersen,et al. The Danish National Hospital Register. A valuable source of data for modern health sciences. , 1999, Danish medical bulletin.
[20] H. Storm,et al. The Danish Cancer Registry--history, content, quality and use. , 1997, Danish medical bulletin.
[21] H. Sørensen,et al. Assessment of the diagnoses of Crohn's disease and ulcerative colitis in a Danish hospital information system. , 1996, Scandinavian journal of gastroenterology.
[22] N. Dubrawsky. Cancer statistics , 2022 .